Literature DB >> 17726477

Adult hippocampal neurogenesis in depression.

Amar Sahay1, Rene Hen.   

Abstract

The development of new treatments for depression is predicated upon identification of neural substrates and mechanisms that underlie its etiology and pathophysiology. The heterogeneity of depression indicates that its origin may lie in dysfunction of multiple brain regions. Here we evaluate adult hippocampal neurogenesis as a candidate mechanism for the etiology of depression and as a substrate for antidepressant action. Current evidence indicates that adult hippocampal neurogenesis may not be a major contributor to the development of depression, but may be required for some of the behavioral effects of antidepressants. We next revisit the functional differentiation of the hippocampus along the septo-temporal axis within the context of adult hippocampal neurogenesis and suggest that neurogenesis in the ventral dentate gyrus may be preferentially involved in regulation of emotion. Finally, we speculate on how increased adult hippocampal neurogenesis may modulate dentate gyrus function to confer the behavioral effects of antidepressants.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17726477     DOI: 10.1038/nn1969

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  420 in total

Review 1.  Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders.

Authors:  Marcello Leopoldo; Enza Lacivita; Francesco Berardi; Roberto Perrone; Peter B Hedlund
Journal:  Pharmacol Ther       Date:  2010-10-20       Impact factor: 12.310

2.  A postmortem assessment of mammillary body volume, neuronal number and densities, and fornix volume in subjects with mood disorders.

Authors:  Hans-Gert Bernstein; Melanie Klix; Henrik Dobrowolny; Ralf Brisch; Johann Steiner; Hendrik Bielau; Tomasz Gos; Bernhard Bogerts
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-02-17       Impact factor: 5.270

Review 3.  Preclinical studies modeling deep brain stimulation for depression.

Authors:  Clement Hamani; José N Nobrega
Journal:  Biol Psychiatry       Date:  2012-06-29       Impact factor: 13.382

Review 4.  Linking molecules to mood: new insight into the biology of depression.

Authors:  Vaishnav Krishnan; Eric J Nestler
Journal:  Am J Psychiatry       Date:  2010-09-15       Impact factor: 18.112

5.  Pterostilbene, an active component of the dragon's blood extract, acts as an antidepressant in adult rats.

Authors:  Liang Yang; Yuanyuan Ran; Zhenzhen Quan; Ran Wang; Qinghu Yang; Qiutian Jia; Heao Zhang; Yanhui Li; Yiheng Peng; JianHua Liang; Hui Wang; Hiroshi Nakanishi; Yulin Deng; Hong Qing
Journal:  Psychopharmacology (Berl)       Date:  2019-01-04       Impact factor: 4.530

6.  Neuronal plasticity and antidepressant actions.

Authors:  Eero Castrén; René Hen
Journal:  Trends Neurosci       Date:  2013-02-01       Impact factor: 13.837

7.  Brain-Derived Neurotrophic Factor Induces Cell Survival and the Migration of Murine Adult Hippocampal Precursor Cells During Differentiation In Vitro.

Authors:  Leonardo Ortiz-López; Nelly Maritza Vega-Rivera; Harish Babu; Gerardo Bernabé Ramírez-Rodríguez
Journal:  Neurotox Res       Date:  2016-09-24       Impact factor: 3.911

8.  Neural stem cell- and neurogenesis-related gene expression profiles in the young and aged dentate gyrus.

Authors:  Geetha A Shetty; Bharathi Hattiangady; Ashok K Shetty
Journal:  Age (Dordr)       Date:  2013-01-16

9.  A neural pathway controlling motivation to exert effort.

Authors:  Christophe D Proulx; Sage Aronson; Djordje Milivojevic; Cris Molina; Alan Loi; Bradley Monk; Steven J Shabel; Roberto Malinow
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-11       Impact factor: 11.205

10.  What keeps a body moving? The brain-derived neurotrophic factor val66met polymorphism and intrinsic motivation to exercise in humans.

Authors:  Ann E Caldwell Hooper; Angela D Bryan; Martin S Hagger
Journal:  J Behav Med       Date:  2014-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.